Skip to main content
Log in

Small Bowel Adenocarcinoma: a Nationwide Population-Based Study

  • Original Research
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Purpose

Small intestinal cancers have a non-specific clinical presentation and hence a delayed diagnosis. The prevalence of small intestinal cancers is low, and there are no cost-effective methods of screening. This study aimed to identify clinical characteristics of duodenal and jejunal adenocarcinomas that can assist in the early detection and diagnosis of disease.

Methods

Duodenal adenocarcinoma and jejunal adenocarcinoma in Explorys database (1999–2019) were compared using odds ratio (OR) with 95% confidence intervals. Data on demographic characteristics, risk factors, clinical features, and treatment were collected.

Results

Out of a total of 8100 patients with a diagnosis of primary adenocarcinoma of the small intestine, 5110 are primary adenocarcinoma of duodenum (63%), and 600 are primary adenocarcinoma of jejunum (7.4%). Patients with jejunal adenocarcinoma when compared with patients with duodenal adenocarcinoma are more obese (OR, 1.36) and have a significantly higher prevalence of malignant neoplasm of colon (OR, 3.07), Crohn’s disease (OR, 4.42), and celiac disease (OR, 2.48). Jejunal adenocarcinoma patients presented more frequently with intestinal obstruction (OR, 1.99), whereas duodenal adenocarcinoma patients more commonly presented with iron deficiency anemia (OR, 0.16). Patients with jejunal adenocarcinoma are less likely to undergo therapy with anti-neoplastic agents when compared with duodenal adenocarcinoma (OR, 0.81). There are no differences in patients undergoing surgical intervention or a combination of surgical intervention and antineoplastic therapy.

Conclusions

Jejunal adenocarcinoma is more commonly associated with colorectal cancer, celiac disease, and Crohn’s disease. They also had lower odds of requiring chemotherapeutic agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Availability of Data and Materials

All data and material related to the manuscript have been included with the manuscript.

References

  1. Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. 2009;249:63–71.

    Article  PubMed  Google Scholar 

  2. Key Statistics for Small Intestine Cancer [Internet]. 2020. Available from: https://www.cancer.org/cancer/small-intestine-cancer/about/what-is-key-statistics.html.

  3. Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al. editors. AJCC Cancer Staging Manual [Internet]. 8th ed. Springer International Publishing. 2017. [cited 2020 Nov 6]. Available from: https://www.springer.com/gp/book/9783319406176.

  4. Halfdanarson TR, McWilliams RR, Donohue JH, Quevedo JF. A single-institution experience with 491 cases of small bowel adenocarcinoma. Am J Surg. 2010;199:797–803.

    Article  PubMed  Google Scholar 

  5. Sakae H, Kanzaki H, Nasu J, Akimoto Y, Matsueda K, Yoshioka M, et al. The characteristics and outcomes of small bowel adenocarcinoma: a multicentre retrospective observational study. Br J Cancer. 2017;117:1607–13.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Zhang Z-H, Qiu C-H, Li Y. Different roles of capsule endoscopy and double-balloon enteroscopy in obscure small intestinal diseases. World J Gastroenterol. 2015;21:7297–304.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Legué LM, Bernards N, Gerritse SL, van Oudheusden TR, de Hingh IHJT, Creemers G-JM, et al. Trends in incidence, treatment and survival of small bowel adenocarcinomas between 1999 and 2013: a population-based study in The Netherlands. Acta Oncol. 2016;55:1183–9.

  8. Schottenfeld D, Beebe-Dimmer JL, Vigneau FD. The epidemiology and pathogenesis of neoplasia in the small intestine. Ann Epidemiol. 2009;19:58–69.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Haselkorn T, Whittemore AS, Lilienfeld DE. Incidence of small bowel cancer in the United States and worldwide: geographic, temporal, and racial differences. Cancer Causes Control. 2005;16:781–7.

    Article  PubMed  Google Scholar 

  10. Goodman MT, Matsuno RK, Shvetsov YB. Racial and ethnic variation in the incidence of small-bowel cancer subtypes in the United States, 1995–2008. Dis Colon Rectum. 2013;56:441–8.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Aparicio T, Henriques J, Manfredi S, Tougeron D, Bouché O, Pezet D, et al. Small bowel adenocarcinoma: results from a nationwide prospective ARCAD-NADEGE cohort study of 347 patients. Int J Cancer. 2020;147:967–77.

    Article  CAS  PubMed  Google Scholar 

  12. Boffetta P, Hazelton WD, Chen Y, Sinha R, Inoue M, Gao YT, et al. Body mass, tobacco smoking, alcohol drinking and risk of cancer of the small intestine–a pooled analysis of over 500,000 subjects in the Asia Cohort Consortium. Ann Oncol. 2012;23:1894–8.

    Article  CAS  PubMed  Google Scholar 

  13. Bennett CM, Coleman HG, Veal PG, Cantwell MM, Lau CCL, Murray LJ. Lifestyle factors and small intestine adenocarcinoma risk: a systematic review and meta-analysis. Cancer Epidemiol. 2015;39:265–73.

    Article  PubMed  Google Scholar 

  14. Palascak-Juif V, Bouvier AM, Cosnes J, Flourié B, Bouché O, Cadiot G, et al. Small bowel adenocarcinoma in patients with Crohn’s disease compared with small bowel adenocarcinoma de novo. Inflamm Bowel Dis. 2005;11:828–32.

    Article  PubMed  Google Scholar 

  15. Elriz K, Carrat F, Carbonnel F, Marthey L, Bouvier AM, Beaugerie L, et al. Incidence, presentation, and prognosis of small bowel adenocarcinoma in patients with small bowel Crohn’s disease: a prospective observational study. Inflamm Bowel Dis. 2013;19:1823–6.

    PubMed  Google Scholar 

  16. Han Y, Chen W, Li P, Ye J. Association between coeliac disease and risk of any malignancy and gastrointestinal malignancy: a meta-analysis. Medicine (Baltimore). 2015;94:e1612.

  17. Ursi P, Tarallo M, Crocetti D, Cavallaro G, Fiori E, D’Andrea V, et al. Second jejunal loop adenocarcinoma associated with celiac disease: the first case report. G Chir. 2019;40:225–9.

    CAS  PubMed  Google Scholar 

  18. Vecchio R, Marchese S, Gangemi P, Alongi G, Ferla F, Spataro C, et al. Laparoscopic treatment of mucinous adenocarcinoma of jejunum associated with celiac disease. Case report G Chir. 2012;33:126–8.

    CAS  PubMed  Google Scholar 

  19. Bridge MF, Perzin KH. Primary adenocarcinoma of the jejunum and ileum. A clinicopathologic study Cancer. 1975;36:1876–87.

    CAS  PubMed  Google Scholar 

  20. Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer. 2004;101:518–26.

    Article  PubMed  Google Scholar 

  21. Talamonti MS, Goetz LH, Rao S, Joehl RJ. Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management. Arch Surg. 2002;137:564–70; discussion 570–571.

  22. Nakanoko T, Koga T, Taketani K, Hirayama Y, Yoshiya S, Minagawa R, et al. Characteristics and treatment strategies for small bowel adenocarcinoma in advanced-stage cases. Anticancer Res. 2015;35:4135–8.

    PubMed  Google Scholar 

  23. Duerr D, Ellard S, Zhai Y, Taylor M, Rao S. A retrospective review of chemotherapy for patients with small bowel adenocarcinoma in British Columbia. J Cancer. 2016;7:2290–5.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Overman MJ, Kopetz S, Lin E, Abbruzzese JL, Wolff RA. Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine. Acta Oncol. 2010;49:474–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All the authors contributed to the study conception and design. Abdul Mohammed, Sophie Trujillo, and Sara Ghoneim performed the material preparation, analysis, and preparation of the manuscript. Critical review of the manuscript and final editing were performed by Neethi Paranji and Nisheet Waghray. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Abdul Mohammed or Nisheet Waghray.

Ethics declarations

Ethics Approval

This is an observational study. The MetroHealth Research Ethics Committee has confirmed that no ethical approval is required.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mohammed, A., Trujillo, S., Ghoneim, S. et al. Small Bowel Adenocarcinoma: a Nationwide Population-Based Study. J Gastrointest Canc 54, 67–72 (2023). https://doi.org/10.1007/s12029-021-00653-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-021-00653-7

Keywords

Navigation